Weekly PhD Newsletter | SIGN UP NOW Weekly PhD Newsletter | SIGN UP NOW
The University of Edinburgh, Centre for Regenerative Medicine PhD Opportunities

About Us

The MRC Centre for Regenerative Medicine (CRM) is a world leading research centre based at the University of Edinburgh. Scientists and clinicians at CRM study stem cells, disease and tissue repair to advance human health.

CRM is housed within the Scottish Centre for Regenerative Medicine (SCRM) building, on the Edinburgh Bioquarter site shared by the Royal Infirmary Hospital and the University's Clinical Research facilities. With new state-of-the-art facilities and a 230+ team of scientists and clinicians, CRM is positioned uniquely to translate scientific knowledge to industry and the clinic. Research at CRM is aimed at developing new treatments for major diseases including cancer, heart disease, liver failure, diabetes, and degenerative diseases such as multiple sclerosis and Parkinson's.

We also train the next generation of basic and clinical scientists and act as a centre for public engagement and source of advice for policy makers.

Training Programme

  • Strong interdisciplinary research and teaching environment
  • 3 and 4 year PhD Training Programmes aimed at science and medical graduates
  • 60 PhD Students on average
  • Interactive discussions, theoretical and practical stem cell research in a lively intellectual environment
  • Specialist lectures and short practical modules covering key technologies
  • Student Discussion Clubs
  • Access to genetic and transferable skills training, provided by through the Universities Institute for Academic Development (IAD)
  • Outreach Training

Our Strengths

  • Excellence in basic and clinical stem cell science
  • Integrated platforms for translational research, including blood, liver and brain
  • Located at the heart of an expanding biomedical campus in Edinburgh
  • Well-resourced for the future
  • Leading training and public engagement program

Our PhD Projects

Application Deadline: 5th December 2014
Interviews will be held w/c 12 January 2015

Leading science, pioneering therapies.